Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells
Open Access
- 1 July 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 5 (7) , 1864-1872
Abstract
Clioquinol, an 8-hydroxyquinoline derivative (5-chloro-7-iodo-8-hydroxyquinoline) with antimicrobial properties, has recently been found to have cytotoxic activity towards human cancer cell lines at concentrations achieved by oral administration. This study was initiated to determine whether clioquinol could potentiate the antitumor effects of two drugs, doxorubicin and docosahexaenoic acid (DHA), believed to act in part via the generation of reactant oxidant species. At low micromolar concentrations, clioquinol had little effect upon cell viability and did not potentiate doxorubicin's cytotoxicity. Clioquinol significantly enhanced DHA's cytotoxic effects, an interaction that was shown to be synergistic by isobolographic analysis. Clioquinol exhibited a synergistic interaction with DHA in reducing nuclear factor-κB activity and inducing apoptosis, and the combination reduced the level of several molecules that promote cell survival, including Akt, p65, and Bcl-2. Interestingly, clioquinol neither induced lipid peroxidation itself nor increased peroxidation brought about by the addition of DHA. However, when cells were pretreated with antioxidant vitamin E, the synergism of clioquinol and DHA was blocked, indicating the essential role of lipid peroxidation for their action. These findings reveal a novel antitumor drug combination that synergistically targets major cell survival signaling pathways. [Mol Cancer Ther 2006;5(7):1864–72]Keywords
This publication has 36 references indexed in Scilit:
- Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cellsBreast Cancer Research and Treatment, 2005
- Overcoming limitations of natural anticancer drugs by combining with artificial agentsTrends in Pharmacological Sciences, 2005
- Phase II study of high‐dose fish oil capsules for patients with cancer‐related cachexiaCancer, 2004
- Laboratory and Clinical Evidence of Synergistic Cytotoxicity of Sequential Treament With Gemcitabine Followed by Docetaxel in the Treatment of SarcomaJournal of Clinical Oncology, 2004
- Saturated Fatty Acid Activates but Polyunsaturated Fatty Acid Inhibits Toll-like Receptor 2 Dimerized with Toll-like Receptor 6 or 1Journal of Biological Chemistry, 2004
- Therapeutic Synergy Between Irinotecan and 5-Fluorouracil against Human Tumor XenograftsClinical Cancer Research, 2004
- Synergistic Capsicum–tea mixtures with anticancer activityJournal of Pharmacy and Pharmacology, 2003
- Docosahexaenoic acid enhances arsenic trioxide–mediated apoptosis in arsenic trioxide–resistant HL-60 cellsBlood, 2003
- Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic MiceNeuron, 2001
- Fish oil, lipid peroxidation and mammary tumor growth.Journal of the American College of Nutrition, 1995